INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9560	Companies
188837	Keywords
120585	Articles
100787	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 07/09/2025 at 22:10, 5 months 10 days ago

Nominations stratégiques chez Inventiva pour renforcer la R&D et les affaires réglementaires

Nominations R&D Affaires Réglementaires Inventiva MASH
PRESS RELEASE

published on 07/09/2025 at 22:05, 5 months 10 days ago

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
Inventiva appoints Jason Campagna as President of R&D and CMO and Martine Zimmermann as EVP of Regulatory Affairs and Quality Assurance, emphasizing long-term growth and operational excellence

Quality Assurance R&D Leadership Appointments Regulatory Affairs Inventiva
PRESS RELEASE

published on 07/09/2025 at 22:05, 5 months 10 days ago

Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité

Nomination R&D Affaires Réglementaires Inventiva Lanifibranor
BRIEF

published on 07/07/2025 at 22:05, 5 months 12 days ago

Inventiva Receives $10 Million Milestone Payment from CTTQ

Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
BRIEF

published on 07/07/2025 at 22:05, 5 months 12 days ago

Inventiva reçoit un paiement d'étape de 10 millions de dollars du CTTQ

Paiement D'étape Lanifibranor Développement Biopharmaceutique Traitement MASH Partenariat CTTQ
PRESS RELEASE

published on 07/07/2025 at 22:00, 5 months 12 days ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva reçoit un paiement d'étape de 10 millions de dollars de la part de CTTQ pour le développement de thérapies contre la stéatohépatite. Accord de licence avec potentiel de 265 millions de dollars supplémentaires

Paiement Inventiva Stéatohépatite Thérapies CTTQ
PRESS RELEASE

published on 07/07/2025 at 22:00, 5 months 12 days ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions

Inventiva Milestone Payment MASH Lanifibranor CTTQ
BRIEF

published on 07/02/2025 at 22:05, 5 months 17 days ago

Inventiva publie des résultats prometteurs sur le lanifibranor pour les maladies du foie

Étude De Phase 2b Maladie Du Foie Lanifibranor Traitement MASH Journal Des Rapports D'hépatologie
BRIEF

published on 07/02/2025 at 22:05, 5 months 17 days ago

Inventiva Publishes Promising Results on Lanifibranor for Liver Disease

Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
PRESS RELEASE

published on 07/02/2025 at 22:00, 5 months 17 days ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization

Accesswire

Published on 12/20/2025 at 00:30, 15 hours 2 minutes ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 17 hours 32 minutes ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 21 hours 2 minutes ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 1 day ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 day 2 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/20/2025 at 10:05, 5 hours 27 minutes ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 17 hours 29 minutes ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 17 hours 52 minutes ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 18 hours 57 minutes ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 20:15, 19 hours 17 minutes ago

CSDS EU RNS Name Changes (19 December 2025)

Les Echos

Published on 12/19/2025 at 21:57, 17 hours 35 minutes ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 7 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 7 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 8 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 8 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE